Jeff Yass’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-396,300
Closed -$2.58M 10581
2014
Q2
$2.58M Sell
396,300
-390,700
-50% -$2.31M ﹤0.01% 4172
2014
Q1
$4.34M Buy
787,000
+207,100
+36% +$1.04M ﹤0.01% 3079
2013
Q4
$2.57M Buy
579,900
+412,200
+246% +$1.39M ﹤0.01% 3865
2013
Q3
$501K Buy
167,700
+87,200
+108% +$250K ﹤0.01% 6421
2013
Q2
$185K Buy
+80,500
New +$163K ﹤0.01% 7498

Jeff Yass's CHTP Position: Q2 2014 in Review

Jeff Yass sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 403,632 shares — an estimated $2.38M sold.

Jeff Yass first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $2.23M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Jeff Yass reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Jeff Yass sold 403,632 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $2.38M.
  • Jeff Yass first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Jeff Yass's CHELSEA THERAPEUTICS INT'L LTD position peaked at $2.23M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Susquehanna International Group's 13F filing for Q2 2014, filed 14 Aug 2014.